Literature DB >> 19507319

Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Interim final rule with request for comments.

.   

Abstract

The Ryan Haight Online Pharmacy Consumer Protection Act, which was enacted on October 15, 2008, amended the Controlled Substances Act and Controlled Substances Import and Export Act by adding several new provisions to prevent the illegal distribution and dispensing of controlled substances by means of the Internet. DEA is hereby issuing an interim rule to amend its regulations to implement the legislation and is requesting comments on the interim rule.

Mesh：

Substances：

Year:  2009        PMID： 19507319

Source DB:  PubMed          Journal:  Fed Regist        ISSN： 0097-6326


  10 in total

1.  Growing Internet use may help explain the rise in prescription drug abuse in the United States.

Authors:  Anupam B Jena; Dana P Goldman
Journal:  Health Aff (Millwood)       Date:  2011-05-12       Impact factor: 6.301

Review 2.  Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment.

Authors:  Thomas O Cole; Darlene Robinson; Andrea Kelley-Freeman; Devang Gandhi; Aaron D Greenblatt; Eric Weintraub; Annabelle M Belcher
Journal:  Front Public Health       Date:  2021-01-21

3.  Online medication purchasing during the Covid-19 pandemic: potential risks to patient safety and the urgent need to develop more rigorous controls for purchasing online medications, a pilot study from the United Arab Emirates.

Authors:  Ammar Abdulrahman Jairoun; Sabaa Saleh Al-Hemyari; Naseem Mohammed Abdulla; Faris El-Dahiyat; Maimona Jairoun; Saleh Karamah Al-Tamimi; Zaheer-Ud-Din Babar
Journal:  J Pharm Policy Pract       Date:  2021-04-30

4.  Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage.

Authors:  Benjamin A Barsky; Alisa B Busch; Sadiq Y Patel; Ateev Mehrotra; Haiden A Huskamp
Journal:  JAMA Netw Open       Date:  2022-01-04

5.  Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky.

Authors:  Feitong Lei; Michelle R Lofwall; Patricia R Freeman; Emily Slade; Rachel Vickers-Smith; Svetla Slavova
Journal:  J Rural Health       Date:  2022-05-24       Impact factor: 5.667

6.  Medication for Opioid Use Disorder Service Provision and Telephone Counseling: A Concurrent Mixed-Methods Approach.

Authors:  Rosemarie Martin; Augustine W Kang; Audrey A DeBritz; Mary R Walton; Ariel Hoadley; Courtney DelaCuesta; Linda Hurley
Journal:  Int J Environ Res Public Health       Date:  2021-06-07       Impact factor: 3.390

7.  Bringing chronic-pain care to rural veterans: A telehealth pilot program description.

Authors:  Lisa H Glynn; Jessica A Chen; Timothy C Dawson; Hannah Gelman; Steven B Zeliadt
Journal:  Psychol Serv       Date:  2020-01-16

8.  Health outcomes in patients using no-prescription online pharmacies to purchase prescription drugs.

Authors:  Theodore J Cicero; Matthew Stephen Ellis
Journal:  J Med Internet Res       Date:  2012-12-06       Impact factor: 5.428

9.  Digital social media, youth, and nonmedical use of prescription drugs: the need for reform.

Authors:  Tim K Mackey; Bryan A Liang; Steffanie A Strathdee
Journal:  J Med Internet Res       Date:  2013-07-26       Impact factor: 5.428

Review 10.  Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness.

Authors:  Racha Fadlallah; Fadi El-Jardali; Farah Annan; Hayat Azzam; Elie A Akl
Journal:  Pharmaceut Med       Date:  2016-08-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.